Summary of Key Points Core Viewpoint - The news highlights the recent activities in the IPO market, including companies that have submitted applications, those that have been approved, and those that have faced delays or withdrawn their applications. It also provides insights into the financial performance and future plans of several companies seeking to go public. Group 1: IPO Activities - No companies were listed on the Shanghai Stock Exchange or Shenzhen Stock Exchange from September 15 to September 21 [2] - One company passed the listing committee review on the Shenzhen Main Board and one on the ChiNext during the same period [3] - Three companies were listed on the Hong Kong Stock Exchange during this timeframe [7] Group 2: Company Profiles - Yuan Chuang Co., Ltd. focuses on the R&D, production, and sales of rubber track products for agricultural and engineering machinery [4] - Xin Guang Yi specializes in high-performance special functional materials, including anti-overflow rubber films [5] - You Xun Co., Ltd. develops optical communication transceiver chips, with applications in various network fields [5] - Rong Hui Lithium Industry is engaged in the R&D, production, and sales of lithium products, essential for lithium-ion battery materials [6] Group 3: Financial Data and Fundraising Plans - Mei Lian Co. aims to raise funds for capital investments, including building production facilities and enhancing sales and marketing efforts, with projected revenues of 1.903 billion, 1.453 billion, and 1.523 billion yuan from 2022 to 2024 [26][27] - Xin Element Pharmaceutical plans to use funds for R&D of its core products, with projected losses of 974.22 million and 434 million yuan for 2023 and 2024 [33][34] - Zhong Run Solar Technology intends to establish a new R&D center and has projected revenues of 12.517 billion, 20.838 billion, and 11.32 billion yuan from 2022 to 2024 [35][37] - Hua Qin Technology aims to enhance its R&D capabilities and has projected revenues of 92.646 billion, 85.338 billion, and 109.878 billion yuan from 2022 to 2024 [50][51] Group 4: Market Challenges and Risks - Mei Lian Co. faces challenges such as limited market acceptance and slow adoption of prefabricated steel structures in the industrial sector [27] - Xin Element Pharmaceutical's success heavily relies on the approval of its candidate drugs, facing intense competition and rapid technological changes [34] - Zhong Run Solar Technology is at risk of overcapacity and fluctuating demand in a competitive market [37] - Hua Qin Technology's performance is influenced by consumer demand for smart products and potential changes in industry standards [51]
全球光伏电池龙头中润光能重启港股IPO,华勤技术、北京君正等3家公司拟“A+H”